Selective TASK-1 Inhibitor with a Defined Structure–Activity Relationship Reduces Cancer Cell Proliferation and Viability

Journal of Medicinal Chemistry
2022.0

Abstract

Chemical structures of selective blockers of TASK channels contain aromatic groups and amide bonds. Using this rationale, we designed and synthesized a series of compounds based on 3-benzamidobenzoic acid. These compounds block TASK-1 channels by binding to the central cavity. The most active compound is 3-benzoylamino<i>-N</i>-(2-ethyl-phenyl)-benzamide or <b>F3</b>, blocking TASK-1 with an IC<sub>50</sub> of 148 nM, showing a reduced inhibition of TASK-3 channels and not a significant effect on different K<sup>+</sup> channels. We identified putative F3-binding sites in the TASK-1 channel by molecular modeling studies. Mutation of seven residues to A (I118A, L122A, F125A, Q126A, L232A, I235A, and L239A) markedly decreased the F3-induced inhibition of TASK-1 channels, consistent with the molecular modeling predictions. <b>F3</b> blocks cell proliferation and viability in the MCF-7 cancer cell line but not in TASK-1 knockdown MCF-7 cells, indicating that it is acting in TASK-1 channels. These results indicated that TASK-1 is necessary to drive proliferation in the MCF-7 cancer cell line.

Knowledge Graph

Similar Paper

Selective TASK-1 Inhibitor with a Defined Structure–Activity Relationship Reduces Cancer Cell Proliferation and Viability
Journal of Medicinal Chemistry 2022.0
TASK Channels Pharmacology: New Challenges in Drug Design
Journal of Medicinal Chemistry 2019.0
Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents
Bioorganic &amp; Medicinal Chemistry 2012.0
Synthesis, in vitro structure–activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents
Bioorganic &amp; Medicinal Chemistry 2010.0
Design, synthesis and in vitro evaluation of fangchinoline derivatives as potential anticancer agents
Bioorganic Chemistry 2020.0
N-((1-Benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a New Scaffold that Provides Rapid Access to Antimicrotubule Agents: Synthesis and Evaluation of Antiproliferative Activity Against Select Cancer Cell Lines
Journal of Medicinal Chemistry 2010.0
1-[(2E)-3-Phenylprop-2-enoyl]-1H-benzimidazoles as anticancer agents: synthesis, crystal structure analysis and binding studies of the most potent anticancer molecule with serum albumin
MedChemComm 2015.0
Substituted 2-hydroxy-N-(arylalkyl)benzamides induce apoptosis in cancer cell lines
European Journal of Medicinal Chemistry 2013.0
Synthesis, biological evaluation and molecular docking studies of 1,3,4-thiadiazole derivatives containing 1,4-benzodioxan as potential antitumor agents
Bioorganic &amp; Medicinal Chemistry Letters 2011.0
Discovery of antiproliferative and anti-FAK inhibitory activity of 1,2,4-triazole derivatives containing acetamido carboxylic acid skeleton
Bioorganic &amp; Medicinal Chemistry Letters 2021.0